JT
MIRM icon

Jupiter Topco’s Mirum Pharmaceuticals MIRM Stock Holding History

Jupiter Topco’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$692M Buy
+5,909,184
New +$593M 0.28% 74

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Jupiter Topco's MIRM Position: Q2 2026 in Review

Jupiter Topco opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 5,909,184 shares worth $692M. The stake represents 0.28% of the portfolio and ranks #74 among its holdings.

300 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Jupiter Topco held 5,909,184 shares of Mirum Pharmaceuticals worth $692M as of Q2 2026.
  • Mirum Pharmaceuticals was a new Jupiter Topco position in Q2 2026.
  • Mirum Pharmaceuticals made up 0.28% of Jupiter Topco's portfolio in Q2 2026, its #74 holding.
  • 300 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.